National HealthCare (NYSE: NHC) director sells 1,779 shares at $225

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported a sale of company common stock. On 2026-08-25 he sold 1,779 shares of common stock in an open-market or private transaction at $225.42 per share, and now directly holds 1,030 shares of NHC common stock.

Insider Trade Summary

Net Seller: 1,779 shares

Net Sell 1 txn

Insider Gifford David R.

Role Director

Sold 1,779 shs ($401K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,779	$225.42	$401K

Holdings After Transaction: Common Stock — 1,030 shares (Direct)

Key Figures

Shares sold: 1,779 shares of Common Stock Sale price per share: $225.42 per share Shares owned after transaction: 1,030 shares of Common Stock +1 more

4 metrics

Shares sold 1,779 shares of Common Stock Sale by director David R. Gifford on 2026-08-25

Sale price per share $225.42 per share Open-market or private transaction on 2026-08-25

Shares owned after transaction 1,030 shares of Common Stock Direct ownership by David R. Gifford after the sale

Net shares sold 1,779 shares Net-sell direction across all transactions in this Form 4

Key Terms

Form 4, open-market or private transaction, Rule 10b5-1

3 terms

Form 4 regulatory

"Reported on <b>Form 4</b> as an insider transaction in NHC stock"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market or private transaction financial

"Transaction code S described as an <b>open-market or private transaction</b>"

Rule 10b5-1 regulatory

"The Rule <b>10b5-1</b> checkbox is not marked for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did NHC director David R. Gifford report?

He reported a sale of 1,779 shares of NATIONAL HEALTHCARE CORP common stock on 2026-08-25 in an open-market or private transaction at $225.42 per share.

How many NHC shares does David R. Gifford own after this transaction?

After the reported sale, David R. Gifford directly owns 1,030 shares of NATIONAL HEALTHCARE CORP common stock.

Was the NHC insider sale made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, indicating the reported sale was not affirmed as being made under a Rule 10b5-1 trading plan.

What price did the NHC shares sell for in this insider transaction?

The 1,779 shares of NATIONAL HEALTHCARE CORP common stock were sold at a price of $225.42 per share.

Is this NHC Form 4 transaction in derivative securities?

No. The reported transaction involves Common Stock only, with no derivative securities reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/28/2026 - 04:56 PM Accepted by SEC EDGAR 08/28/2026 - 04:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gifford David R.

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2026		S		1,779	D	$225.42	1,030	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ David R. Gifford	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)